Hemogenomics Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore., Karnataka, India, established in 2002.
2002 Bangalore., Karnataka, India Active
Last Updated:
Access Report
About Hemogenomics Private Limited

Hemogenomics Private Limited, a active private limited company, was established on 22 January 2002 in Bangalore., Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U73100KA2002PTC030032. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.23 Cr.

It upholds a compliant status. Employing 99 professional, Its leadership includes Anurag Bagaria (Director), Sumit Bagaria (Managing Director), Francisco Jose Dopazo Gonzalez (Director). Past directors included William J Rutter, Ashok Sekhar Ganguly, Anurag Bagaria. It holds ₹68.54 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Kemwell House,No.11, Tumkur Road Bangalore., Bangalore., Karnataka, 560022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2002PTC030032

  • Registration Number

    030032

  • Incorporation Date

    22 January 2002

  • Authorized Capital

    ₹4.00 Cr

  • Paid-Up Capital

    ₹2.23 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 2.23 Cr
  • Company Age 24 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 68.54 Cr
  • Revenue Growth **** 3.05%
  • Profit Growth **** -7.29%
  • Ebitda **** -0.36%
  • Net Worth 12.68%
  • Total Assets **** 26.63%
Company report

Hemogenomics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Hemogenomics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Hemogenomics Private Limited?
Current Directors
Name Designation Appointment Date Status
Anurag Bagaria Director 08 Mar 2010 Current
Sumit Bagaria Managing Director 18 Jan 2011 Current
Francisco Jose Dopazo Gonzalez Director 10 Jan 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Jan 2025 Past
Pramod Abcsdd Director 11 Nov 2010 Past
Pramod Abcsdd Additional Director 23 Sep 2010 Past
Pramod Abcsdd Director 07 Apr 2015 Past
Pramod Abcsdd Nominee Director 19 Mar 2010 Past
Pramod Abcsdd Additional Director 29 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hemogenomics.

Hemogenomics Private Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 3.05% increase. The company also saw a slight decrease in profitability, with a 7.29% decrease in profit. The company's net worth Soared by an impressive increase of 12.68%.

Hemogenomics revenue growth over time
Hemogenomics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.05%
*******
*******
*******
*******
Revenue from Operations
*******
 1.94%
*******
*******
*******
*******
Total Assets
*******
 26.63%
*******
*******
*******
*******
Profit or Loss
*******
 -7.29%
*******
*******
*******
*******
Net Worth
*******
 12.68%
*******
*******
*******
*******
EBITDA
*******
 -0.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hemogenomics?

In 2023, Hemogenomics had a promoter holding of 65.02% and a public holding of 34.99%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹685,366,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 40.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 27.50 Cr
  • Others : 1.04 Cr
Latest Charge Details
Date Lender Amount Status
28 Jun 2025 The Hongkong And Shanghai Banking Corporation Limited ₹27.50 Cr Open
20 Feb 2025 Others ₹1.04 Cr Open
02 Mar 2016 Citi Bank N.A. ₹5.00 Cr Open
11 Jan 2012 Citi Bank N.A. ₹35.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Hemogenomics?

Hemogenomics has a workforce of 99 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hemogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemogenomics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hemogenomics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Hemogenomics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 27.50 Cr with Charge ID 101118743 was registered on 28 Jun 2025. was recorded as a recent event.

  • Balance Sheet

    The activity Hemogenomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 1.04 Cr with Charge ID 101080855 was registered on 20 Feb 2025. was completed.

  • Director Appointment

    The activity Francisco Jose Dopazo Gonzalez was appointed as a Director was appointed as a Director on 10 Jan 2025 & has been associated with this company since 1 year 3 months . was completed.

  • Charges

    The activity A charge with Citi Bank N.A. of Rs. 35.00 Cr registered on 11 Jan 2012 with Charge ID 10337103 was modified on 15 Feb 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hemogenomics Private Limited?

The CIN of Hemogenomics Private Limited is U73100KA2002PTC030032.

Where is Hemogenomics Private Limited headquartered?

Hemogenomics Private Limited is headquartered at Kemwell House,No.11, Tumkur Road Bangalore., Bangalore., Karnataka, 560022.

When was Hemogenomics Private Limited incorporated?

Hemogenomics Private Limited was incorporated on 22 January 2002.

Who are the current directors of Hemogenomics Private Limited?

The current directors of Hemogenomics Private Limited are

What is the primary industry of Hemogenomics Private Limited?

The primary industry of Hemogenomics Private Limited is Hospital And Medical Care.

Is Hemogenomics Private Limited a listed company?

Hemogenomics Private Limited is unlisted.

What is the capital structure of Hemogenomics Private Limited?

The authorized capital of Hemogenomics Private Limited is ₹4.00 Cr, and the paid-up capital is ₹2.23 Cr.

What is the compliance status of Hemogenomics Private Limited?

The compliance status of Hemogenomics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available